Discover and read the best of Twitter Threads about #HesterBiosciences
Most recents (2)
Annual Report No : 2
Highlights of #Hesterbiosciences Annual Report FY 21
Like & retweet for max reach ! 🐤🐥
1. About
Hester Biosciences is one of the biggest animal and poultry healthcare companies in India engaged in manufacturing of vaccines and healthcare products.
Highlights of #Hesterbiosciences Annual Report FY 21
Like & retweet for max reach ! 🐤🐥
1. About
Hester Biosciences is one of the biggest animal and poultry healthcare companies in India engaged in manufacturing of vaccines and healthcare products.
The sole focus of the company is to improve the health quality of animals and poultry by monitoring and preventing and curing diseases through seamless supply of vaccines and medicines and supplements.
Hester also works with customers and offers technical services to provide health solutions.
2. Revenue Split
The domestic business of Hester accounted for 81% of revenues whereas exports accounted for 10%. The remaining 9% came from other geographies.
2. Revenue Split
The domestic business of Hester accounted for 81% of revenues whereas exports accounted for 10%. The remaining 9% came from other geographies.
#HesterBiosciences Q3 FY22 concall highlights 🐓🐓
Like & Retweet for better reach !
1. Revenues are flat and profitability is down because of the high base effect.
Like & Retweet for better reach !
1. Revenues are flat and profitability is down because of the high base effect.
2. Q3 and Q4 of FY21 were phenomenal quarters for the company because there was a major poultry disease outbreak which led to increased demand for vaccines.
3. They also have additional income every year from licensing fees which is not there in Q3 FY22.
3. They also have additional income every year from licensing fees which is not there in Q3 FY22.
4. They have been working on 3 vaccines - classical swine fever, lumpy skin disease and sheep pox vaccine. All these vaccines are in the final stages of quality testing and regulatory approval and they hope to launch them in Q1 FY23.
